317 related articles for article (PubMed ID: 8361131)
41. The renin-angiotensin system and renal function in kidney transplantation.
Mimran A; Mourad G; Ribstein J
Kidney Int Suppl; 1990 Nov; 30():S114-7. PubMed ID: 2259069
[TBL] [Abstract][Full Text] [Related]
42. The renal renin-angiotensin system.
Harrison-Bernard LM
Adv Physiol Educ; 2009 Dec; 33(4):270-4. PubMed ID: 19948673
[TBL] [Abstract][Full Text] [Related]
43. [The tissue renin-angiotensin systems].
Neri Serneri GG; Boddi M; Coppo M; Chechi T
Ann Ital Med Int; 1993 Oct; 8 Suppl():87S-96S. PubMed ID: 8117527
[TBL] [Abstract][Full Text] [Related]
44. Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function.
DiBona GF
Hypertension; 2000 Dec; 36(6):1083-8. PubMed ID: 11116129
[TBL] [Abstract][Full Text] [Related]
45. [Progression of renal dysfunction. Possibilities of nephroprotection with ACE inhibitors].
Schollmeyer P; Lehnert T; Böhler J
Internist (Berl); 1992 Aug; 33 Suppl 1():S46-52. PubMed ID: 1428698
[No Abstract] [Full Text] [Related]
46. Effects of ACE inhibition on renal haemodynamics in essential hypertension and hypertension associated with chronic renal failure.
Sánchez RA; Traballi CA; Marcó EJ; Gilbert BH; Ramírez AJ; Long G
Drugs; 1991; 41 Suppl 1():25-30. PubMed ID: 1712268
[TBL] [Abstract][Full Text] [Related]
47. Localisation and physiological effects of tissue renin-angiotensin systems.
Swales JD; Samani NJ
J Hum Hypertens; 1989 Jun; 3 Suppl 1():71-7. PubMed ID: 2674444
[TBL] [Abstract][Full Text] [Related]
48. Tissue renin-angiotensin system: a site of drug action?
Zimmerman BG; Dunham EW
Annu Rev Pharmacol Toxicol; 1997; 37():53-69. PubMed ID: 9131246
[TBL] [Abstract][Full Text] [Related]
49. Intrarenal renin-angiotensin system in primitive vertebrates.
Nishimura H; Bailey JR
Kidney Int Suppl; 1982 Aug; 12():S185-92. PubMed ID: 6752535
[TBL] [Abstract][Full Text] [Related]
50. Control of blood pressure by the renin-angiotensin-aldosterone system.
Hall JE
Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV6-21; discussion IV51-5. PubMed ID: 1893644
[TBL] [Abstract][Full Text] [Related]
51. Independent regulation of renin-angiotensin-aldosterone system in the kidney.
Nishiyama A; Kobori H
Clin Exp Nephrol; 2018 Dec; 22(6):1231-1239. PubMed ID: 29600408
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin converting enzyme inhibition and the kidney.
Hollenberg NK
Curr Opin Cardiol; 1988; 3(Suppl 1):S19-29. PubMed ID: 11538849
[TBL] [Abstract][Full Text] [Related]
53. Renal protective effects of angiotensin converting enzyme inhibitors.
Weder AB
Am J Hypertens; 1990 Nov; 3(11):273S-277S. PubMed ID: 2261145
[TBL] [Abstract][Full Text] [Related]
54. [The renin-angiotensin system and blood pressure regulation].
Mann J
Dtsch Med Wochenschr; 1994 Jul; 119(27):965-6. PubMed ID: 8026312
[No Abstract] [Full Text] [Related]
55. Effects of angiotensin II and of angiotensin converting enzyme inhibition in chronic renal failure.
Ledingham JG
Kidney Int Suppl; 1987 May; 20():S112-6. PubMed ID: 3037159
[No Abstract] [Full Text] [Related]
56. [Renin-angiotensin-aldosterone system].
Suzuki H
Nihon Rinsho; 2004 Jun; 62 Suppl 6():153-6. PubMed ID: 15250285
[No Abstract] [Full Text] [Related]
57. Blood pressure, angiotensin-converting enzyme (ACE) inhibitors, and the kidney.
MacGregor GA
Am J Med; 1992 Apr; 92(4B):20S-27S. PubMed ID: 1580276
[TBL] [Abstract][Full Text] [Related]
58. Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease--pathophysiological considerations.
Rudnicki M; Mayer G
Pharmacogenomics; 2003 Mar; 4(2):153-62. PubMed ID: 12605549
[TBL] [Abstract][Full Text] [Related]
59. ACE inhibitors and the kidney. A risk-benefit assessment.
Navis G; Faber HJ; de Zeeuw D; de Jong PE
Drug Saf; 1996 Sep; 15(3):200-11. PubMed ID: 8879974
[TBL] [Abstract][Full Text] [Related]
60. The intrarenal renin-angiotensin system.
Mulrow PJ
Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):41-4. PubMed ID: 7922165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
